– the leading provider of online annual reports to individual and institutional investors.

Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc., a commercial stage biopharmaceutical company, involves in the identification, development, and commercialization of therapies for multiple sclerosis (MS), spinal cord injury, and other nervous system disorders.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports